tiprankstipranks
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market

Monte Rosa Therapeutics (GLUE) Income Statement

Compare
275 Followers

Monte Rosa Therapeutics Income Statement

Last quarter (Q3 2024), Monte Rosa Therapeutics's total revenue was $9.22M, an increase of Infinity% from the same quarter last year. In Q3, Monte Rosa Therapeutics's net income was $-23.86M. See Monte Rosa Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -6.22M$ -8.56M$ -2.13M$ -537.00K$ -72.00K
Operating Expenses
$ 143.31M$ 112.38M$ 72.88M$ 28.01M$ 7.99M
Depreciation and Amortization
$ 6.22M$ 8.56M$ 2.13M$ 537.00K$ 72.00K
EBITDA
$ -137.09M$ -99.94M$ -70.75M$ -27.47M$ -7.67M
Operating Income
$ -143.31M$ -112.38M$ -72.88M$ -28.01M$ -7.99M
Other Income/Expenses
$ 8.30M$ 3.88M$ -1.08M$ -7.87M$ 254.00K
Pretax Income
$ -135.01M$ -108.50M$ -73.96M$ -35.88M$ -7.74M
Net Income
$ -135.35M$ -104.62M$ -71.94M$ -36.07M$ -8.02M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.63$ -2.22$ -1.55$ -0.82$ -0.18
Diluted EPS
$ -2.63$ -2.22$ -1.55$ -0.82$ -0.18
Weighted Average Shares Outstanding
51.40M 47.23M 46.54M 44.00M 44.00M
Weighted Average Shares Outstanding (Diluted)
51.40M 47.23M 46.54M 44.00M 44.00M
Currency in USD

Monte Rosa Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis